Animal Models & Clinical Trials

The development of human vaccines continues to rely on the use of animals for research. Regulatory authorities require novel vaccine candidates to undergo preclinical assessment in animal models before being permitted to enter the clinical phase in human subjects. Substantial progress has been made in recent years in reducing and replacing the number of animals used for preclinical vaccine research through the use of bioinformatics and computational biology to design new vaccine candidates. However, the ultimate goal of a new vaccine is to instruct the immune system to elicit an effective immune response against the pathogen of interest, and no alternatives to live animal use currently exist for evaluation of this response. 

  • Animal models in vaccine development
  • Innovations and clinical trials in vaccination
  • Diagnostic and clinical applications
  • Engineered mouse models in cancer
  • Research and development of viral vaccines, including field trials

Related Conference of Animal Models & Clinical Trials

September 18-19, 2017

20th Global Summit & Expo on Vaccines, Immunization & B2B

(Global B2B Meetings in 1 Event) Houston, Texas USA
October 05-07, 2017

World Vaccines and Immunization Congress

Osaka, Japan
October 30-31, 2017

19th International Vaccines & B2B Congress

Chicago, USA
August 09-10, 2018

27th Euro Congress on Cancer Science & Therapy

Madrid, Spain

Animal Models & Clinical Trials Conference Speakers

Recommended Sessions

Related Journals

Are you interested in